Search details
1.
L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma.
Mod Pathol
; 37(5): 100467, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38460672
2.
The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy.
Cancer
; 129(23): 3790-3796, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-37584213
3.
Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy.
J Urol
; 210(1): 54-63, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37096575
4.
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.
J Urol
; 210(1): 46-53, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37096582
5.
Measuring cancer burden in prostatic needle core biopsies: simplified assessments outperform complex measurements in assessing outcome: evidence to assist pathologist efficiency and minimize datasets.
Histopathology
; 82(7): 1021-1028, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36779238
6.
Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations.
Pediatr Blood Cancer
; 70(8): e30434, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37243318
7.
Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes.
Radiology
; 302(3): 595-602, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34931855
8.
Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.
Mod Pathol
; 35(6): 825-835, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34949764
9.
Prevalence of High-Risk Prostate Cancer Metastasis to Cloquet's Ilioinguinal Lymph Node.
J Urol
; 207(6): 1222-1226, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35050701
10.
Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer.
J Urol
; 208(2): 309-316, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35363038
11.
Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series.
Histopathology
; 81(2): 246-254, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35758203
12.
Clinical utility of subclassifying positive surgical margins at radical prostatectomy.
BJU Int
; 129(2): 194-200, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34161656
13.
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma.
Mod Pathol
; 34(2): 445-456, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32879414
14.
Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging Findings.
J Urol
; 205(4): 1055-1062, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33207133
15.
Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center.
J Urol
; 203(6): 1117-1121, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31909690
16.
Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience.
J Urol
; 203(6): 1122-1127, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31868556
17.
Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder.
J Pathol
; 248(3): 260-265, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30838648
18.
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer.
Int J Urol
; 27(2): 179-185, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31833113
19.
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.
Mod Pathol
; 32(9): 1329-1343, 2019 09.
Article
in English
| MEDLINE | ID: mdl-30980040
20.
Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile.
Mod Pathol
; 32(5): 701-709, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30622286